An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

C.M. Sanders; C.A. Langley; J. Persaud; J.F. Marriott; K.A. Wilson

doi:10.1211/096176703777341345

An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

C.M. Sanders
, C.A. Langley
, J. Persaud
, J.F. Marriott
, K.A. Wilson

Aston University
Birmingham Women's NHS Foundation Trust

Research output: Contribution to journal › Conference abstract › peer-review

Abstract

Poster session
- Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form
- It is not uncommon for alcohol to be present in liquid preparations, often as a solvent
- Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity
- It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol
- The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

Original language	English
Pages (from-to)	R37
Number of pages	1
Journal	International Journal of Pharmacy Practice
Volume	11
Issue number	S1
DOIs	https://doi.org/10.1211/096176703777341345
Publication status	Published - Sept 2003
Event	British Pharmaceutical Conference 2003 - Harrogate, United Kingdom Duration: 15 Sept 2003 → 17 Sept 2003

Access to Document

10.1211/096176703777341345

Cite this

@article{803721748ea9491b8a16ab9c510ca287,

title = "An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients",

abstract = "Poster session - Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form - It is not uncommon for alcohol to be present in liquid preparations, often as a solvent - Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity - It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol - The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination",

author = "C.M. Sanders and C.A. Langley and J. Persaud and J.F. Marriott and K.A. Wilson",

year = "2003",

month = sep,

doi = "10.1211/096176703777341345",

language = "English",

volume = "11",

pages = "R37",

journal = "International Journal of Pharmacy Practice",

issn = "0961-7671",

publisher = "Oxford University Press",

number = "S1",

note = "British Pharmaceutical Conference 2003 ; Conference date: 15-09-2003 Through 17-09-2003",

}

TY - JOUR

T1 - An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

AU - Sanders, C.M.

AU - Langley, C.A.

AU - Persaud, J.

AU - Marriott, J.F.

AU - Wilson, K.A.

PY - 2003/9

Y1 - 2003/9

N2 - Poster session - Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form - It is not uncommon for alcohol to be present in liquid preparations, often as a solvent - Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity - It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol - The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

AB - Poster session - Paediatric cystic fibrosis and liver patients can be prescribed a number of different pharmaceutical preparations, often in liquid form - It is not uncommon for alcohol to be present in liquid preparations, often as a solvent - Although the quantity of alcohol present can be low, patients taking a number of alcohol-containing preparations may be at risk of toxicity - It has been found that only a few of the preparations used for both paediatric cystic fibrosis and liver patients contain alcohol - The quantity of alcohol present in these preparations is low and should not cause toxicity, even when the products are used in combination

UR - https://onlinelibrary.wiley.com/doi/abs/10.1211/096176703777341345

U2 - 10.1211/096176703777341345

DO - 10.1211/096176703777341345

M3 - Conference abstract

SN - 0961-7671

VL - 11

SP - R37

JO - International Journal of Pharmacy Practice

JF - International Journal of Pharmacy Practice

IS - S1

T2 - British Pharmaceutical Conference 2003

Y2 - 15 September 2003 through 17 September 2003

ER -

An assessment of the alcohol content of medicines commonly used in paediatric liver and cystic fibrosis patients

Abstract

Access to Document

Other files and links

Fingerprint

Financial consequences of one-stop dispensing at Birmingham Children's Hospital

Postgraduate training offered to primary care pharmacists by schools of pharmacy - changes over the last five years

Training and development needs of PCT strategic level pharmacists

Cite this